Neuropacs

Neuropacs is a medical technology company specializing in the early and accurate diagnosis of neurodegenerative diseases through advanced imaging analysis. The company's core platform utilizes a proprietary, AI-driven algorithm to analyze standard clinical MRI scans, providing clinicians with objective data to differentiate between Parkinson's disease and other parkinsonian syndromes. By automating the detection of subtle structural changes in the brain, Neuropacs aims to reduce misdiagnosis rates and accelerate the path to appropriate treatment. Their lead product has received FDA clearance, positioning the company as a leader in non-invasive neurological diagnostics. The technology is designed for seamless integration into existing clinical workflows, offering a scalable solution for neurology clinics worldwide.